Z-2753-2017 Class II Terminated

Recalled by Becton Dickinson & Company — Franklin Lakes, NJ

FDA device recall Z-2753-2017 was initiated by Becton Dickinson & Company on Sep 16, 2016 and is designated Class II. Reason for recall: BD identified that several lots did not receive the specified dose of irradiation necessary to meet the Sterility Assurance Level (SAL) required. The recall status is terminated (terminated Mar 20, 2018). Affected quantity: 1,528,000 units.

Recall details

Product Type
Devices
Report Date
Jul 26, 2017
Initiation Date
Sep 16, 2016
Termination Date
Mar 20, 2018
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1,528,000 units

Product description

BD 3ml Syringer Luer-Lok Tip Catalog #309604 The BD Single Use, Hypodermic Syringe is intended for use by health care professionals for general purpose fluid aspiration/injection

Reason for recall

BD identified that several lots did not receive the specified dose of irradiation necessary to meet the Sterility Assurance Level (SAL) required.

Distribution pattern

Nationwide Distribution

Code information

6061746 2021-02 6082982 2021-02 6089821 2021-03 6117858 2021-04 6117863 2021-04 6117889 2021-04 6117891 2021-04 6146962 2021-04 6173697 2021-05 6173767 2021-06 6173779 2021-06 6208614 2021-07

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-2753-2017
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-2753-2017. Report a data issue: hello@regdatalab.com.